Monoclonal Antibodies for Management of Gi Cancer

Gold, David V.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 3R01CA043218-03S1
• Application #: 3185297
• Study Section: Experimental Immunology Study Section (EI)
• Project Start: 1987-04-15
• Project End: 1990-03-31
• Budget Start: 1989-04-01
• Budget End: 1990-03-31
• Support Year: 3
• Fiscal Year: 1990

Institution

• Name: Center for Molecular Medicine/Immunology
• City: Belleville
• State: NJ
• Country: United States
• Zip Code: 07950

Publications

Mariani, G; Molea, N; Bacciardi, D et al. (1995) Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer. Cancer Res 55:5911s-5915s

Gold, D V; Lew, K; Maliniak, R et al. (1994) Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int J Cancer 57:204-10

Sharkey, R M; Gold, D V; Aninipot, R et al. (1990) Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens. Cancer Res 50:828s-834s

Gold, D V; Nocera, M A; Stephens, R et al. (1990) Murine monoclonal antibodies to colon-specific antigen p. Cancer Res 50:6405-9

Gold, D V; Ishizaki, G; Keller, P et al. (1989) Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma. Cancer Res 49:6412-8

Gold, D V; Mattes, M J (1988) Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates. Tumour Biol 9:137-44